All News about Gamida Cell Ltd
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
January 20, 2022
Topics
Death
Exposures
Death
Gamida Cell Provides Update on Omidubicel BLA Submission
January 19, 2022
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Ltd. (NASDAQ:GMDA) Shareholder Alert: Investigation over Possible Violations of Securities Laws
December 13, 2021
Via SBWire
Exposures
Product Safety
Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
December 11, 2021
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 16, 2021
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript
November 16, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update
November 15, 2021
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel
November 11, 2021
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast
November 08, 2021
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting
November 04, 2021
From Gamida Cell Ltd.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.